Tyme Technologies Inc (NASDAQ:TYME) Shorted Shares Decreased By 18.24%

June 27, 2018 - By Arnold Ferreira

Tyme Technologies Inc (NASDAQ:TYME) had a decrease of its shares shorted by 18.24%. It was announced in June by FINRA the 285,600 shares shorted on TYME. The 349,300 previous shares are down with 18.24%. 2 days will cost TYME with 163,500 average volume to restore its previous position. Float short on Tyme Technologies Inc is 1.14%.

Ticker’s shares touched $3.57 during the last trading session after 3.51% change.Currently Tyme Technologies, Inc. is uptrending after 3.14% change in last June 27, 2017. TYME has also 43,085 shares volume. TYME underperformed the S&P 500 by 9.43%.

Tyme Technologies, Inc., a clinical-stage pharmaceutical company, focuses on the discovery and development of cancer therapeutics for various oncology indications.The company has $361.38 million market cap. It is developing SM-88, a combination therapy in Phase II development for prostate cancer.Last it reported negative earnings.

More recent Tyme Technologies, Inc. (NASDAQ:TYME) news were published by Globenewswire.com, Nasdaq.com and Nasdaq.com. The first one has “Tyme Technologies, Inc. Set to Join Russell 3000® Index” as a title and was published on June 25, 2018. The next is “Tyme Appoints Pharma Executive Don DeGolyer to Board of Directors” on May 30, 2018. And last was published on June 12, 2018, called “Tyme Releases Detailed Data and Analyses with SM-88 From the First Human Study and Compassionate Use Programs”.

Tyme Technologies, Inc. (NASDAQ:TYME) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: